|
4. DÉPISTAGE, DIAGNOSTIC ET PRONOSTIC
|
|
|
|
4.16 DÉP., DIAG. & PRONO. - PANCRÉAS
|
|
|
|
|
4.9 DÉP., DIAG. & PRONO. - SEIN
|
|
|
|
5.10 TRAITEMENTS - ESSAIS
|
|
|
|
5.12 IMMUNOTHÉRAPIES
|
|
|
|
5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE
|
|
|
|
5.2 PHARMA
|
|
|
|
|
|
5.2.3 PHARMA - ÉCONOMIE
|
|
|
|
|
|
5.3 TRAITEMENTS - FDA, EMA, NICE...
|
|
|
|
|
|
5.4 TRAITEMENTS - ECONOMIE
|
|
|
|
5.5.1 ASCO (GÉNÉRAL)
|
|
|
|
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More [Xconomy]
|
|
|
|
|
|
We’ll wrap up ASCO with highlights and context on the immunotherapy wins and losses, the continued push toward more genetically focused pills, the first glimpses of data from places cancer treatment has never been, and a step up in the race to make blood tests to find cancer in otherwise healthy people.
|
|
|
|
|
|
|
5.5.1.1 ASCO (GÉNÉRAL) - INDUSTRIELS
|
|
|
|
Was ASCO 2019 'quiet'? Pharma, biotech execs weigh in [Fierce Pharma]
|
|
|
|
|
|
The way Baselga sees it, “these meetings have to change.” “They have to become more thematic and they have to be more, I think, more opinion forums where to engage in discussions and where to engage in debates and where to engage in educational opportunities more than just the pure novelty of clinical studies.”
|
|
|
|
|
|
|
|
5.5.4.5 ASCO (IMMUNOTHÉRAPIES-CAR-T, THÉRAPIES CELLULAIRES)
|
|
|
Outlining the Risks That Go Along With the Benefit of CAR T-Cell Therapy [AJMC]
|
|
|
|
|
|
“CAR T-cell therapy is truly now the 4th arm of treatment for cancer patients and has allowed our patients to get great therapeutic rewards. However, about half of the patients included in the study that was the basis of approval for Yescarta needed ICU [intensive care unit] management. In 3 of the published studies to date [for the therapies], almost all the patients developed some grade of cytokine release syndrome.”
|
|
|
|
|
|
|
6. LUTTE CONTRE LES CANCERS
|
|
|
|
6.10.1 POLITIQUES (USA)
|
|
|
|
6.5 MÉDECINES ALTERNATIVES/COMPLÉMENTAIRES
|
|
|
Katie Britton-Jordan: Sadly, vegan diets don’t cure cancer [Respectful Insolence]
|
|
|
|
|
|
Katie Britton-Jordan, from Derbyshire, was diagnosed with stage 2a triple negative breast cancer in July 2016. She claimed chemotherapy, proven to save lives, was like ‘poisoning your body’ and opted to take an alternative approach. Mrs Britton-Jordan, thought to be 40, also refused a mastectomy and radiotherapy. She passed away on Saturday.
|
|
|
|
|
|
|
6.6 PUBLICATIONS
|
|
|
|
|
|
6.7 DMP, BIG DATA & APPLIS
|
|
|
|
6.8 COMMUNICATION
|
|
|
|
6.9 CONTROVERSES
|
|
|